Aaron L. Sharpe

Fraunhofer USA Center for Manufacturing Innovation

Papers

1

Total Citations

60

H-Index

1

About

Aaron L. Sharpe is a pioneering researcher at the intersection of biotechnology and automation, best known for his groundbreaking work in plant-based pharmaceutical production. His most influential contribution is the development of the first fully automated "factory" that leverages tobacco plants to rapidly produce vaccines and therapeutic biologics. This innovative system, detailed in his highly cited 2012 paper (60 citations), utilizes plant viral vector technology to generate specific proteins within fast-growing tobacco leaves, enabling the large-scale manufacture of complex medicines within weeks rather than months. Sharpe's work addresses critical bottlenecks in traditional pharmaceutical manufacturing, offering a scalable, cost-effective platform for producing life-saving biologics, including pandemic-response vaccines. His research has profound implications for global health, particularly in low-resource settings where rapid, decentralized production is essential. By merging plant molecular farming with automated bioprocessing, Sharpe has established a new paradigm for agile, on-demand drug manufacturing, earning recognition as a transformative figure in synthetic biology and biopharmaceutical engineering.

Research Focus

Key Achievements

1
H-Index
1
Papers
60
Total Citations
60
Avg Citations/Paper
🏆 Most Cited Paper
Automated Production of Plant-Based Vaccines and Pharmaceuticals
60 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Fraunhofer USA Center for Manufacturing Innovation

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago